4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-16-124284
Executive VP, R&D acquired 122,162 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shaaltiel Yoseph Executive VP, R&D | 2016-09-15 | Option exercise | +122,162 | $0.00 | $122 | 585,916 | D |
| Derivatives | |||||||
| Shaaltiel Yoseph Executive VP, R&D | 2016-09-15 | Option exercise · Stock Options (Right to Buy) | −122,162 | 0 | D | ||
Loading xslF345X03/v448888_4.xml…